Craig-Hallum Maintains Buy on Neuraxis, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 72.7%

Neg 0% Neu 0% Pos 72.7%

Craig-Hallum analyst Chase Knickerbocker maintains Neuraxis (AMEX:NRXS) with a Buy and raises the price target from $8 to $13.